PubMed Health⌕ Search

PubMed · 2661123

Cardiopulmonary exercise testing.

Abstract

Cardiopulmonary exercise testing is an objective method of assessing the functional capacity of a patient. In contrast to clinical assessment and resting investigations, exercise testing is useful in detecting early changes in patients with cardiac or respiratory disease. Although a number of different types of ergometers can be used for testing, the ones used commonly are the cycle and treadmill. Comparison of these two modes of exercise shows no significant clinical difference between them; therefore, either can be used for routine cardiopulmonary exercise testing. There are various types of exercise protocols, but generally the protocol should involve large muscle groups and should be tolerated by the population being tested. The main goal when selecting an exercise protocol is to strike a balance between workload increments that do not prematurely fatigue the subject and at the same time allow the subject to reach a maximum power output within 8 to 15 minutes. Whatever the exercise test protocol used, the intensity should be increased to a symptom-limited maximum. This procedure is safe as long as contraindications for starting a test and indications for terminating a test are adhered to strictly. The assessment of cardiorespiratory responses during exercise ranges from simple and noninvasive techniques to those that are invasive and complex. In the majority of cases all the information needed for proper assessment of the patient can be acquired with simple noninvasive techniques.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R S McKelvie, N L Jones. 1989. Cardiopulmonary exercise testing.. https://pubmed.ncbi.nlm.nih.gov/2661123/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Bilateral thoracoscopic cervical sympathectomy for the treatment of recurrent polymorphic ventricular tachycardia.

Congenital long QT syndrome (LQTS) is a disorder of prolonged cardiac repolarisation, manifest by a prolonged QT interval and characterised by recurrent presyncope/syncope, polymorphic ventricular tachycardia (PMVT), or sudden cardiac death. A 46 year old woman with no family history of sudden death or deafness presented with recurrent syncope. Physical examination and electrolytes were normal and a 12 lead ECG showed a corrected QT interval of 458 ms. A monitored syncopal episode documented PMVT. Despite potassium and magnesium supplements, beta blockade, implantation of a single then dual chamber implantable cardioverter defibrillator (ICD), amiodarone, nicorandil, and mexiletine, the patient continued to experience arrhythmia storms, receiving more than 700 ICD discharges over seven months. She was ultimately treated successfully with bilateral thoracoscopic cervicothoracic sympathectomies. This is the first reported bilateral thoracoscopic treatment of a patient with LQTS and symptomatic life threatening ventricular tachyarrhythmias refractory to current pharmacological and pacing techniques.

Electrocardiography↗